InsiderClue
Insiders · Profile

COX CARRIE SMITH

Director at Texas Instruments · Executive Chair at Organon · Director at Cartesian Therapeutics · and 3 more. Filing since 20 Apr 2007. CIK 0001110753

TXN Texas Instruments Director · 10 trades OGN Organon & Co. Executive Chair · 2 trades RNAC Cartesian Therapeutics, Inc. Director · 2 trades ECOR electroCore, Inc. Director · 3 trades CAH Cardinal Health Director · 1 trade MRK Merck & Co. Executive Vice President · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
TXN Texas Instruments
13 May 2026
Director
Sold at will
8,838
$2.71M
19.0%
OGN Organon & Co.
12 Nov 2025
Executive Chair
Bought
65,400
$501.76K
525%
OGN Organon & Co.
14 May 2025
Director
Bought
12,469
$100.59K
opened
TXN Texas Instruments
31 Jul 2023
Director
Sold at will
16,055
$2.89M
31.0%
RNAC Cartesian Therapeutics, Inc.
13 Jun 2022
Director
Bought
130,000
$149.80K
157%
RNAC Cartesian Therapeutics, Inc.
3 Dec 2021
Director
Bought
17,200
$50.66K
26.2%
TXN Texas Instruments
23 Oct 2020
Director
Sold, plan not stated
22,838
$3.41M
40.1%
TXN Texas Instruments
24 Jul 2020
Director
Sold, plan not stated
26,905
$3.50M
44.1%
ECOR electroCore, Inc.
6 Jun 2019
Director
Bought
10,000
$18.20K
90.9%
TXN Texas Instruments
29 Apr 2019
Director
Sold, plan not stated
17,002
$1.97M
33.8%
ECOR electroCore, Inc.
3 Dec 2018
Director
Bought
7,300
$49.59K
197%
ECOR electroCore, Inc.
17 Aug 2018
Director
Bought
3,700
$50.92K
27.8%
TXN Texas Instruments
27 Jul 2017
Director
Sold, plan not stated
14,000
$1.15M
30.8%
TXN Texas Instruments
28 Jul 2015
Director
Sold, plan not stated
22,000
$1.10M
43.8%
TXN Texas Instruments
25 Jul 2013
Director
Sold, plan not stated
15,000
$585.00K
38.3%
CAH Cardinal Health
14 May 2013
Director
Bought
435
$20.12K
3.2%
TXN Texas Instruments
25 Apr 2008
Director
Bought
1,674
$48.80K
19.8%
TXN Texas Instruments
10 Aug 2007
Director
Bought
600
$19.73K
11.2%
MRK Merck & Co.
1 May 2007
Executive Vice President
Sold, plan not stated
450,000
$14.18M
83.1%
MRK Merck & Co.
20 Apr 2007
Executive Vice President
Sold, plan not stated
450,000
$13.88M
83.1%
20 decisions on file.